Test Research Inc. (3030)
TWSE
313.50
0.00 (0.00%)
Closed
Oct 8, 2026
Day's Range
307.00316.00
52 wk Range
139.50457.50
Financial Statements - 3030 - Test Research Inc.
Revenue
8.46B▲ 33.2%
Net Income
2.47B▲ 35.0%Net Margin 29.3%
EBITDA
3.20B▲ 34.8%
Free Cash Flow
1.42B▲ 85.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 8.46B | 6.35B | 4.43B | 6.70B | 5.60B | 4.95B |
| Cost of Goods | 3.52B | 2.57B | 1.80B | 2.86B | 2.55B | 2.23B |
| Gross Profit | 4.94B | 3.78B | 2.63B | 3.84B | 3.04B | 2.71B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 2.99B | 2.03B | 1.20B | 2.15B | 1.55B | 1.44B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 2.99B | 2.17B | 1.25B | 2.45B | 1.55B | 1.37B |
| Income Tax | 517.80M | 341.14M | 253.98M | 532.36M | 372.44M | 280.58M |
| Net Income | 2.47B | 1.83B | 1B | 1.92B | 1.18B | 1.09B |
| EPS Basic | 10.49 | 7.78 | 4.24 | 8.13 | 5.02 | 4.63 |
| EPS Diluted | 10.48 | 7.76 | 4.23 | 8.11 | 5.01 | 4.62 |
| Basic Shares Outstanding | 236.21M | 236.21M | 236.21M | 236.21M | 236.21M | 236.21M |
| Diluted Shares Outstanding | 236.21M | 236.21M | 236.21M | 236.21M | 236.21M | 236.21M |
| Ebit | 2.99B | 2.18B | 1.25B | 2.45B | 1.55B | 1.37B |
| Ebitda | 3.20B | 2.37B | 1.39B | 2.60B | 1.69B | 1.50B |
| Net Income Continuous Operations | 2.99B | 2.17B | 1.25B | 2.45B | 1.55B | 1.37B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
